METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): DIAGNOSTIC CRITERIA AND EMERGING PHARMACOTHERAPY . ITFTTDM [Internet]. 2026 Sep. 26 [cited 2026 Oct. 9];4(9):129-31. Available from: https://universalpublishings.com/index.php/itfttdm/article/view/20686